TY - JOUR
T1 - Intrathecal analgesia for refractory cancer pain
AU - Newsome, Scott
AU - Frawley, Bridget K.
AU - Argoff, Charles E.
N1 - Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2008
Y1 - 2008
N2 - The use of intrathecal analgesics is an important treatment consideration for many patients with chronic cancer pain. This review describes the various opioid and nonopioid analgesics that have been used in this setting, including morphine, hydromorphone, fentanyl, meperidine, methadone, sufentanil, local anesthetics, clonidine, ketamine, baclofen, midazolam, betamethasone, and octreotide. We discuss available evidence for their analgesic and adverse effects.
AB - The use of intrathecal analgesics is an important treatment consideration for many patients with chronic cancer pain. This review describes the various opioid and nonopioid analgesics that have been used in this setting, including morphine, hydromorphone, fentanyl, meperidine, methadone, sufentanil, local anesthetics, clonidine, ketamine, baclofen, midazolam, betamethasone, and octreotide. We discuss available evidence for their analgesic and adverse effects.
UR - http://www.scopus.com/inward/record.url?scp=58149183079&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58149183079&partnerID=8YFLogxK
U2 - 10.1007/s11916-008-0043-0
DO - 10.1007/s11916-008-0043-0
M3 - Review article
C2 - 18625101
AN - SCOPUS:58149183079
SN - 1531-3433
VL - 12
SP - 249
EP - 256
JO - Current pain and headache reports
JF - Current pain and headache reports
IS - 4
ER -